← Leaderboards
Daniel R Deaver
Paasp Us, Llc
$844,250
Attributed
$1,688,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $963K · FY2020–21$1M$750K$500K$250K$0
'20
'21
Funding mix
By agency
NIH$1,688,500 · 1
By mechanism
R44$1,688,500 · 1
Top collaborators
- Andre Der-Avakian3 shared
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentAreaAutomatic Information ProcessingAutomationBaseBiomedical ResearchBusinessesCapitalCategoriesCertificationClinical ResearchClinical TreatmentCodeComputerized Data ProcessingComputer SimulationCostCost EffectiveCosts And BenefitsData AnalysesData FormatData IntegrityDecision MakingDesignAcademia
Grant awards (3)
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications$725,450
R44 · FY2021 · DA · contact PI
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications$739,750
R44 · FY2020 · DA · contact PI
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications$223,300
R44 · FY2020 · DA · contact PI